Title |
ACMG clinical laboratory standards for next-generation sequencing
|
---|---|
Published in |
Genetics in Medicine, July 2013
|
DOI | 10.1038/gim.2013.92 |
Pubmed ID | |
Authors |
Heidi L. Rehm, Sherri J. Bale, Pinar Bayrak-Toydemir, Jonathan S. Berg, Kerry K. Brown, Joshua L. Deignan, Michael J. Friez, Birgit H. Funke, Madhuri R. Hegde, Elaine Lyon |
Abstract |
Next-generation sequencing technologies have been and continue to be deployed in clinical laboratories, enabling rapid transformations in genomic medicine. These technologies have reduced the cost of large-scale sequencing by several orders of magnitude, and continuous advances are being made. It is now feasible to analyze an individual's near-complete exome or genome to assist in the diagnosis of a wide array of clinical scenarios. Next-generation sequencing technologies are also facilitating further advances in therapeutic decision making and disease prediction for at-risk patients. However, with rapid advances come additional challenges involving the clinical validation and use of these constantly evolving technologies and platforms in clinical laboratories. To assist clinical laboratories with the validation of next-generation sequencing methods and platforms, the ongoing monitoring of next-generation sequencing testing to ensure quality results, and the interpretation and reporting of variants found using these technologies, the American College of Medical Genetics and Genomics has developed the following professional standards and guidelines. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 22 | 52% |
Australia | 2 | 5% |
United Kingdom | 2 | 5% |
Bosnia and Herzegovina | 1 | 2% |
France | 1 | 2% |
Montenegro | 1 | 2% |
Comoros | 1 | 2% |
China | 1 | 2% |
South Africa | 1 | 2% |
Other | 1 | 2% |
Unknown | 9 | 21% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 23 | 55% |
Scientists | 18 | 43% |
Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 13 | 1% |
United Kingdom | 8 | <1% |
Brazil | 4 | <1% |
Spain | 3 | <1% |
South Africa | 3 | <1% |
Italy | 3 | <1% |
Germany | 2 | <1% |
Canada | 2 | <1% |
France | 1 | <1% |
Other | 11 | 1% |
Unknown | 1001 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 228 | 22% |
Student > Ph. D. Student | 153 | 15% |
Other | 131 | 12% |
Student > Master | 115 | 11% |
Student > Bachelor | 74 | 7% |
Other | 167 | 16% |
Unknown | 183 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 272 | 26% |
Agricultural and Biological Sciences | 268 | 25% |
Medicine and Dentistry | 176 | 17% |
Computer Science | 23 | 2% |
Immunology and Microbiology | 22 | 2% |
Other | 80 | 8% |
Unknown | 210 | 20% |